x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:13:09

EHA 2025: MaaT Pharma presented an update for its...

BiotechTV - News ·

2025/06/14

CMO Gianfranco Pittari walks us through data from the pivotal ARES study that MaaT announced in January and filed with the EMA. Plus, an EHA presentation from an early access program that is a follow-up from data we saw in ASH in December.

en-us

00:15:17

Microsoft's Chief Scientific Officer for Health and...

BiotechTV - News ·

2025/06/13

Matthew Lungren describes his belief how AI will "save time before it saves lives," and discusses how the clinical workforce is getting more used to adopting it. Plus how AI might affect cancer care and drug development R&D.

en-us

00:16:26

EHA 2025: CEO Arthur Sands discusses Nurix...

BiotechTV - News ·

2025/06/13

He discusses the P1 data presented at EHA for CLL and WM, which he says showed efficacy across mutations, durability, and clean safety. Plus, recent #AACR25 data on BTK, BRAF and Aurora A, and his toughts on STAT6, IRAK4, and other autoimmune targets.

en-us

00:15:13

EHA 2025: CEO Jonathan Dickinson discusses Innate...

BiotechTV - News ·

2025/06/13

He describes Innate's NK cell platform and covers programs targeting CD20, CD123, BCMA, and B7-H3. Plus Lacutamab data, updates on the company's Nectin-4 ADC, and Monalizumab.

en-us

00:08:42

CLAIRITY BREAST, an AI platform that predicts...

BiotechTV - News ·

2025/06/12

CEO Leff Luber describes the tool, which is mean to augment a radiologist's analysis, and how its modeling algorithm takes into account pixels that may be unseen by the human eye.

en-us

00:09:23

Nucleate UK held its "The Forum" event in London -...

BiotechTV - News ·

2025/06/09

BiotechTV attended the event, and recorded comments from the Nucleate team, who describe the scale and role of Nucleate in this area. We hear about the Activator program, and meet entrepreneurs who have benefitted from it. Plus, how Nucleate has partnered with the government's Advanced Research and Invention Agency (ARIA) in the UK.

en-us

00:10:08

AI News: Artera presented data at #ASCO25 showing...

BiotechTV - News ·

2025/06/06

CMO Tim Showalter describes the finding, which was selected as a "Best of ASCO" oral presentation. Plus, helping to determine how certain patients and ethnic groups will respond to therapies in the real world. and what is next for Artera.

en-us

00:11:26

Kymera Therapeutics' Founder & CEO Nello Mainolfi...

BiotechTV - News ·

2025/06/04

He describes the data, which was released on Monday, and highlights the future of the program - including how we will see more data in atopic dermatitis patients by the end of the year. Plus, discussing a new target Kymera recently announced for other immuno-inflammatory diseases, IRF5.

en-us

00:11:40

ASCO 2025: PharmaMar presented data showing that the...

BiotechTV - News ·

2025/06/03

Global Product Lead José Antonio López-Vilariño describes the data and VP of Strategic Development Pascal Besman puts the result in context of this cancer type and stage that historically has had a very poor prognosis.

en-us

00:14:28

ASCO 2025: France based Transgene presented data for...

BiotechTV - News ·

2025/06/03

Chairman and CEO Alessandro Riva describes the computational work that is done to choose the personalized neoantigens for this cancer vaccine, and he describes why head and neck was a good fit to test the therapy out in. Plus, he covers the data and talks about next steps.

en-us

00:16:11

ASCO 2025: Candel Therapeutics CEO Paul Peter Tak...

BiotechTV - News ·

2025/06/02

He explains the design of the therapy, and covers the data presented at ASCO. Plus, filing and manufacturing plans, and highlighting this program in other cancers.

en-us

00:09:53

ASCO 2025: Strand Therapeutics Co-Founder & CEO Jake...

BiotechTV - News ·

2025/06/02

He explains why IL-12, and how the self-replicating aspect may be giving this more durability over first generation mRNA cancer immunotherapies. He covers the data, and describes how Strand is seeing the abscopal effect in some patients for this intra-tumoral administered product.

en-us

00:14:00

ASCO 2025: Allogene presented data today for a CD70...

BiotechTV - News ·

2025/06/02

CEO David Chang\ describes the data and explains why he believes the company's "Dagger" platform makes a difference. Plus, an update on Allogene's 1L consolidation trial in LBCL, and his thoughts on cell therapy for autoimmune diseases.

en-us

00:14:55

ASCO 2025: The leaders of Daiichi-Sankyo discuss new...

BiotechTV - News ·

2025/06/02

Global Head of Oncology Ken Keller walks us through the company's ASCO data and highlights other future catalysts to watch, which new Global CEO Hiroyuki Okuzawa discusses the company's long-term plans to be a top 10 oncology company.

en-us

00:12:20

Deerfield Management Managing Partner James Flynn...

BiotechTV - News ·

2025/06/02

He describes raising the fund, and his take on the current challenging environment in healthcare. Plus, his thoughts on AI specifically, and how Deerfield is adding new people to both participate in it and invest in it.

en-us

00:15:18

ASCO 2025: Protagonist Therapeutics' CEO Dinesh Patel...

BiotechTV - News ·

2025/06/02

He describes the Rusfertide result, which is partnered with Takeda and was presented in a plenary session at ASCO. Plus, he covers a UC announcement that JNJ made in March, and guides for when Protagonist will announce an obesity program.

en-us

00:09:08

ASCO 2025: Bicara Therapeutics' CEO Claire Mazumdar...

BiotechTV - News ·

2025/06/02

She describes Bicara's data in HPV-negative HNSCC, and explains why the company is focused on this HVP-negative population specifically. Plus, how she believes the data compares to a closely watched competitor has a EGFR x LGR5 program.

en-us

00:12:14

ASCO 2025: Legend Biotech's CEO Ying Huang discusses...

BiotechTV - News ·

2025/06/02

He describes long-term data for CARTITUDE-1 and a subset analysis from CARTITUDE-4. Plus, a DLL3 targeting armored CAR and a Claudin 18.2 program.

en-us

00:11:00

ASCO 2025: Arcus Biosciences' CEO Terry Rosen...

BiotechTV - News ·

2025/06/02

He describes the HIF-2a approach, and today's data release at ASCO, as well as why he believes Casdatifan can be best in class compared to one product that is already on the market.

en-us

00:11:26

ASCO 2025: Arvinas CEO John Houston discusses the...

BiotechTV - News ·

2025/06/01

He describes the trial's success in patients with ESR1 mutations, and discusses the steps ahead for both this program and the protein degradation field in general.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter